0.3987

0.10% 0.0004

Applied Therapeutics Inc (APLT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.3983

Offen:

$0.3956

24-Stunden-Volumen:

1.38M

Relative Volume:

0.57

Marktkapitalisierung:

$47.09M

Einnahmen:

Nettoeinkommen (Verlust:

$-119.76M

KGV:

-0.2953

EPS:

-1.35

Netto-Cashflow:

$-55.17M

1W Leistung:

+19.73%

1M Leistung:

-27.42%

6M Leistung:

-95.27%

1J Leistung:

-90.57%

1-Tages-Spanne:

$0.3867

$0.4103

1-Wochen-Bereich:

$0.3051

$0.4284

52-Wochen-Spanne:

$0.295

$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Firmenname

Applied Therapeutics Inc

Sektor

Healthcare (1154)

Branche

Biotechnology (677)

Telefon

212-220-9226

Adresse

545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY

Mitarbeiter

Twitter

@Applied_Tx

Nächster Verdiensttermin

2025-03-31

Neueste SEC-Einreichungen

APLT's Discussions on Twitter

Vergleichen Sie APLT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
APLT Applied Therapeutics Inc	0.3987	47.09M	0	-119.76M	-55.17M	-1.35
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-23	Herabstufung	William Blair	Outperform → Mkt Perform
2024-12-02	Herabstufung	UBS	Buy → Neutral
2024-11-29	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-07-31	Eingeleitet	William Blair	Outperform
2024-03-26	Eingeleitet	RBC Capital Mkts	Outperform
2024-02-22	Eingeleitet	Leerink Partners	Outperform
2022-01-04	Herabstufung	Barclays	Overweight → Equal Weight
2021-08-27	Herabstufung	Goldman	Neutral → Sell
2021-06-25	Fortgesetzt	Goldman	Neutral
2020-10-08	Eingeleitet	Truist	Buy
2020-04-22	Eingeleitet	Goldman	Buy
2020-02-27	Eingeleitet	Barclays	Overweight
2019-06-10	Eingeleitet	Citigroup	Buy
2019-06-10	Eingeleitet	Cowen	Outperform
2019-06-10	Eingeleitet	Robert W. Baird	Outperform

Alle ansehen

Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten

03:32 AM

Press Release Distribution & PR Platform - ACCESS Newswire

03:32 AM

Apr 24, 2025

Applied Therapeutics Inc (NASDAQ:APLT)’s 12-Month Price Target Is Now Set At 5. - Marketing Sentinel

Apr 24, 2025

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 16, 2025

Apr 15, 2025

Applied Therapeutics Reports 2024 Financial Results and Leadership Changes - TipRanks

Apr 15, 2025

Applied Therapeutics, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Applied Therapeutics (APLT) Reports Lower Revenue But Reinforces Strategic Focus | APLT Stock News - GuruFocus

Apr 15, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Fi - GuruFocus

Apr 15, 2025

Apr 14, 2025

Applied Therapeutics earnings beat by $0.71, revenue fell short of estimates - Investing.com Canada

Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results - The Manila Times

Apr 14, 2025

Applied Therapeutics Strengthens Balance Sheet: $79.4M Cash Position Powers Drug Development Push - Stock Titan

Apr 14, 2025

Apr 13, 2025

Norges Bank Acquires New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 13, 2025

Apr 12, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Apr 12, 2025

Apr 10, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 04, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - MarketScreener

Apr 04, 2025

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline - Investing.com Australia

Apr 03, 2025

Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 03, 2025